Sadrekarimi H, Gardanova Z, Bakhshesh M, Ebrahimzadeh F, Fakhre Yaseri A, Thangavelu L
J Transl Med. 2022; 20(1):301.
PMID: 35794566
PMC: 9258144.
DOI: 10.1186/s12967-022-03492-7.
Lin T, Lan W, Chiu Y, Feng C, Chiu C, Kuo C
Antioxidants (Basel). 2021; 10(8).
PMID: 34439541
PMC: 8389206.
DOI: 10.3390/antiox10081293.
He M, Zheng Y, Ma A, Zhang C, Yu Y, Wang H
Exp Ther Med. 2020; 20(5):47.
PMID: 32952638
PMC: 7480139.
DOI: 10.3892/etm.2020.9176.
McClain M, Beckett A, Cover T
Toxins (Basel). 2017; 9(10).
PMID: 29023421
PMC: 5666363.
DOI: 10.3390/toxins9100316.
Schlaermann P, Toelle B, Berger H, Schmidt S, Glanemann M, Ordemann J
Gut. 2014; 65(2):202-13.
PMID: 25539675
PMC: 4752654.
DOI: 10.1136/gutjnl-2014-307949.
Immune subversion and quorum-sensing shape the variation in infectious dose among bacterial pathogens.
Gama J, Abby S, Vieira-Silva S, Dionisio F, Rocha E
PLoS Pathog. 2012; 8(2):e1002503.
PMID: 22319444
PMC: 3271079.
DOI: 10.1371/journal.ppat.1002503.
Molecular cross-talk between Helicobacter pylori and human gastric mucosa.
Ricci V, Romano M, Boquet P
World J Gastroenterol. 2011; 17(11):1383-99.
PMID: 21472096
PMC: 3070011.
DOI: 10.3748/wjg.v17.i11.1383.
Helicobacter pylori-induced interleukin-12 p40 expression.
Takeshima E, Tomimori K, Teruya H, Ishikawa C, Senba M, DAmbrosio D
Infect Immun. 2009; 77(4):1337-48.
PMID: 19179414
PMC: 2663134.
DOI: 10.1128/IAI.01456-08.
Molecular characterization of Helicobacter pylori VacA induction of IL-8 in U937 cells reveals a prominent role for p38MAPK in activating transcription factor-2, cAMP response element binding protein, and NF-kappaB activation.
Hisatsune J, Nakayama M, Isomoto H, Kurazono H, Mukaida N, Mukhopadhyay A
J Immunol. 2008; 180(7):5017-27.
PMID: 18354227
PMC: 3404739.
DOI: 10.4049/jimmunol.180.7.5017.
Vacuolating cytotoxin in Helicobacter pylori water-soluble proteins upregulates chemokine expression in human eosinophils via Ca2+ influx, mitochondrial reactive oxygen intermediates, and NF-kappaB activation.
Kim J, Kim J, Lee J, Kim Y, Youn H, Kim I
Infect Immun. 2007; 75(7):3373-81.
PMID: 17452475
PMC: 1932938.
DOI: 10.1128/IAI.01940-06.
Eradication of H pylori for the prevention of gastric cancer.
Trautmann K, Stolte M, Miehlke S
World J Gastroenterol. 2006; 12(32):5101-7.
PMID: 16937519
PMC: 4088005.
DOI: 10.3748/wjg.v12.i32.5101.
Modulation of host immune responses by the cytolethal distending toxin of Helicobacter hepaticus.
Pratt J, Sachen K, Wood H, Eaton K, Young V
Infect Immun. 2006; 74(8):4496-504.
PMID: 16861635
PMC: 1539592.
DOI: 10.1128/IAI.00503-06.
Helicobacter pylori: current status and future prospects.
OMahony R, Vaira D, Holton J, Basset C
Sci Prog. 2005; 87(Pt 4):269-96.
PMID: 16028836
PMC: 10367526.
DOI: 10.3184/003685004783238481.
Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion.
Sundrud M, Torres V, Unutmaz D, Cover T
Proc Natl Acad Sci U S A. 2004; 101(20):7727-32.
PMID: 15128946
PMC: 419674.
DOI: 10.1073/pnas.0401528101.